What is the current price and exchange for 2228.HK stock?

2228.HK stock closed at **HK$11.25** on 18 Feb 2026 on the HKSE in Hong Kong. Volume for the session was **14,599,891** shares and the 52-week range is **HK$3.85–HK$15.12**.

How does Meyka AI rate 2228.HK and what does it mean?

Meyka AI rates 2228.HK **62.99/100** (Grade B, HOLD). The grade blends benchmark comparisons, sector data, financial metrics, and forecasts. It is informational and not investment advice.

What are realistic price targets and the implied upside for 2228.HK stock?

Scenario targets are conservative **HK$9.00**, base **HK$11.50**, and bullish **HK$15.00**. Meyka AI quarterly projection **HK$13.19** implies about **+17.24%** upside from **HK$11.25**.

When is the next earnings release for XtalPi (2228.HK)?

XtalPi’s next earnings announcement is scheduled for **2026-03-27**. Investors should watch revenue guidance and client contract updates for directional clarity.

HK Stocks

Market closed 18 Feb 2026: XtalPi (2228.HK) HKSE HK$11.25: AI stocks insight

ByDanny Kontos February 18, 2026

The 2228.HK stock closed the Hong Kong session at HK$11.25 on 18 Feb 2026, up 0.04 or 0.36% from the prior close. Trading volume was 14,599,891, below the 50-day average, as investors digest recent operational updates and sector moves. XtalPi Holdings Ltd (2228.HK) remains an AI-driven drug discovery name listed on the HKSE in Hong Kong. This note summarises valuation, technicals, a Meyka AI forecast, and key catalysts for the stock in the AI stocks strategy.